Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.08% Nasdaq Down0.11%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS

65.76 May 23, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 127,928   131,938   128,117   124,019  
Cost of Revenue20,500  26,532  24,619  23,574  
Gross Profit 107,428   105,406   103,498   100,445  
Operating Expenses
Research Development83,743  84,363  66,209  77,812  
Selling General and Administrative51,050  55,049  46,337  51,539  
Non Recurring -   -   -   -  
Others5,556  12,898  1,443  2,048  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (32,921) (46,904) (10,491) (30,954)
Income from Continuing Operations
Total Other Income/Expenses Net(9,474)(1,007)903  360  
Earnings Before Interest And Taxes(42,796)(48,164)(9,924)(30,492)
Interest Expense1,725  1,930  1,837  1,925  
Income Before Tax(44,521)(50,094)(11,761)(32,417)
Income Tax Expense(4,711)2,918  (6,404)(411)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(40,211)(53,265)(5,693)(31,904)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (39,810) (53,012) (5,357) (32,006)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (39,810) (53,012) (5,357) (32,006)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.